💨 Abstract

President Donald Trump issued an executive order aiming to lower drug prices in the U.S. to match those in other countries. The order sets price targets for drugmakers and threatens tariffs or imports if prices aren't reduced significantly within 30 days. The industry and analysts foresee challenges in implementation and potential legal fights, as similar past efforts were blocked by courts. Drugmaker shares initially dropped but then rallied, as the order was seen as less harmful than expected.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖